Search research articles
Contact Us
Filters
Showing results (21-30 of 144) with videos related to
Page
of 15
Sort By:
Vaccine
|
March 18, 2014
Induction of protective immunity against H1N1 influenza A(H1N1)pdm09 with spray-dried and electron-beam sterilised vaccines in non-human primates
Regina Scherließ, Ankur Ajmera, Mike Dennis, et al.
The Journal of Infectious Diseases
|
June 17, 2026
Molecular phenotypes of sex and age specific differences relating to outcome in patients with Ebola virus disease
Xiaofeng Dong, Natasha Y Rickett, Piet Maes, et al.
Scientific Reports
|
July 26, 2018
Expanding the Arterivirus Host Spectrum: Olivier's Shrew Virus 1, A Novel Arterivirus Discovered in African Giant Shrews
Bert Vanmechelen, Valentijn Vergote, Lies Laenen, et al.
Viruses
|
February 8, 2014
Prevalence of antibodies against hantaviruses in serum and saliva of adults living or working on farms in Yorkshire, United Kingdom
Lisa J Jameson, Autilia Newton, Louise Coole, et al.
Journal of Virological Methods
|
October 26, 2024
Performance of an envelope glycoprotein-based multiplex immunoassay for Ebola virus antibody detection in a cohort of Ebola virus disease survivors
McKenna D Roe, Grace Hood, Spencer L Sterling, et al.
Plos One
|
September 8, 2018
Cellular immune response to human influenza viruses differs between H1N1 and H3N2 subtypes in the ferret lung
Kathryn A Ryan, Gillian S Slack, Anthony C Marriott, et al.
Emerging Microbes & Infections
|
June 17, 2026
The development of biologically contained Sudan virus as an alternative and safe tool for fundamental filovirus research
Jens Verlinden, Joren Stroobants, Kato Govaerts, et al.
European Journal of Medicinal Chemistry
|
June 3, 2026
Cephalosporins are potent SARS-CoV-2 main protease inhibitors
Dorian-Gabriel Muntean, Wojtek Treyde, Dóra Laczi, et al.
The Lancet. Infectious Diseases
|
February 26, 2019
Early transmission and case fatality of Ebola virus at the index site of the 2013-16 west African Ebola outbreak: a cross-sectional seroprevalence survey
Joseph W S Timothy, Yper Hall, Joseph Akoi-Boré, et al.
Cancer Immunology, Immunotherapy : CII
|
December 7, 2007
Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses
Richard Harrop, Noel Drury, William Shingler, et al.
Page
of 15
Search research articles
Search
Showing results (21-30 of 144) with videos related to
Sort By:
Page
of 15
Vaccine
|
March 18, 2014
Induction of protective immunity against H1N1 influenza A(H1N1)pdm09 with spray-dried and electron-beam sterilised vaccines in non-human primates
Regina Scherließ, Ankur Ajmera, Mike Dennis, et al.
The Journal of Infectious Diseases
|
June 17, 2026
Molecular phenotypes of sex and age specific differences relating to outcome in patients with Ebola virus disease
Xiaofeng Dong, Natasha Y Rickett, Piet Maes, et al.
Scientific Reports
|
July 26, 2018
Expanding the Arterivirus Host Spectrum: Olivier's Shrew Virus 1, A Novel Arterivirus Discovered in African Giant Shrews
Bert Vanmechelen, Valentijn Vergote, Lies Laenen, et al.
Viruses
|
February 8, 2014
Prevalence of antibodies against hantaviruses in serum and saliva of adults living or working on farms in Yorkshire, United Kingdom
Lisa J Jameson, Autilia Newton, Louise Coole, et al.
Journal of Virological Methods
|
October 26, 2024
Performance of an envelope glycoprotein-based multiplex immunoassay for Ebola virus antibody detection in a cohort of Ebola virus disease survivors
McKenna D Roe, Grace Hood, Spencer L Sterling, et al.
Plos One
|
September 8, 2018
Cellular immune response to human influenza viruses differs between H1N1 and H3N2 subtypes in the ferret lung
Kathryn A Ryan, Gillian S Slack, Anthony C Marriott, et al.
Emerging Microbes & Infections
|
June 17, 2026
The development of biologically contained Sudan virus as an alternative and safe tool for fundamental filovirus research
Jens Verlinden, Joren Stroobants, Kato Govaerts, et al.
European Journal of Medicinal Chemistry
|
June 3, 2026
Cephalosporins are potent SARS-CoV-2 main protease inhibitors
Dorian-Gabriel Muntean, Wojtek Treyde, Dóra Laczi, et al.
The Lancet. Infectious Diseases
|
February 26, 2019
Early transmission and case fatality of Ebola virus at the index site of the 2013-16 west African Ebola outbreak: a cross-sectional seroprevalence survey
Joseph W S Timothy, Yper Hall, Joseph Akoi-Boré, et al.
Cancer Immunology, Immunotherapy : CII
|
December 7, 2007
Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses
Richard Harrop, Noel Drury, William Shingler, et al.
Page
of 15